Default company panoramic image
A5864920 91f1 4c67 a53c 2294aff1fcbf

Dermadis

Dermadis is developing a biologic to treat dermatology disorders by controlling specific biological pathways.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Archamps, RA, France
  • Currency USD
  • Founded February 2010
  • Employees 4
  • Website dermadis.com

Company Summary

The company, which got the young innovative status (JEI) is located in a cluster of biotech companies. Dermadis was founded to firstly develop inhibitors of kallikreins in the dermatology field. The recent discoveries of the importance of kallikreins in skin diseases, and the potential of kallikrein inhibitors as therapeutic agents in dermatological disorders are the core business of Dermadis. XXX patients are waiting for efficient treatment.

Team

  • Default avatar
    David Deperthes
    Chairman

  • Default avatar
    Christoph Kundig
    Managing Director & CSO

Previous Investors

  • Default avatar
    Private investment, Mr. Henrick Heegaard
    Unconfirmed
    Default avatar
    OSEO
    Unconfirmed